| NCT ID | NCT07503067 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mclean Hospital |
| Condition | Substance Use Disorder (SUD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-02-10 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-02-10 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to develop a new tool for measuring substance use disorder treatment outcome. We will start by interviewing people and gathering advisory groups to develop the items for this new tool.
Eligibility Criteria
Inclusion Criteria: * (1) ability to read and provide informed consent in English, and at least one of the following 2a) currently providing direct care to patients with substance use disorders, 2b) current or past treatment for an substance use disorder, or 2c) self-report of a close friend or family member who currently or previously received treatment for a substance use disorder. Exclusion Criteria: * 1\) major psychiatric or medical condition that would interfere with participation (e.g., acute psychosis, severe withdrawal); 2) current intoxication (positive breath alcohol test or behavioral evidence of other substance intoxication).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07503067 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Substance Use Disorder (SUD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07503067 currently recruiting?
Yes, NCT07503067 is actively recruiting participants. Contact the research team at kmchugh@mclean.harvard.edu for enrollment information.
Where is the NCT07503067 trial being conducted?
This trial is being conducted at Belmont, United States.
Who is sponsoring the NCT07503067 clinical trial?
NCT07503067 is sponsored by Mclean Hospital. The trial plans to enroll 50 participants.